← Back to Patent Explorer
US4342687A Expired / Lapsed US ⏱️ 0.0 years remaining

N-Substituted perhydrodioxazepines useful as polyurethane catalysts

Assignee: Texaco Inc
•
Filing: 1981-09-08
•
Granted: 1982-08-03
•
Expires: 2001-09-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A primary amine may be reacted with formaldehyde and a 1,2-diol to produce N-substituted perhydrodioxazepines of the formula: ##STR1## where R is alkyl, alkoxyalkyl, aminoalkyl or aryl alkyl and R' is hydrogen or lower alkyl. These compounds may be easily prepared and have a low odor which is essential in their utility as polyurethane catalysts. By varying the R group, the catalytic characteristics of the compounds may be altered as desired.

Inventors

  • 👤 Robert L. Zimmerman
  • 👤 Edward E. McEntire

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 20:29
CPC Classifications
C; C07; C07D; C07D273/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 23 words
A composition of matter having the formula ##STR4## where R is a tertiary amino alkyl radical and R' is hydrogen or lower alkyl.
Claim 2
Dependent Claim 23 words
A composition of matter having the formula ##STR4## where R is a tertiary amino alkyl radical and R' is hydrogen or lower alkyl.
Claim 3
Dependent Claim 7 words
The composition of matter consisting of 3-[3-(dimethylamino)propyl]perhydrodioxazepine-1,5,3.
Claim 4
Dependent Claim 7 words
The composition of matter consisting of 3-[3-(dimethylamino)propyl]perhydrodioxazepine-1,5,3.
Claim 5
Dependent Claim 8 words
The composition of matter consisting of 3-(3-morpholinopropyl)-6-methyl perhydrodioxazepine-1,5,3.
Claim 6
Dependent Claim 8 words
The composition of matter consisting of 3-(3-morpholinopropyl)-6-methyl perhydrodioxazepine-1,5,3.
Claim 7
Dependent Claim 7 words
The composition of matter consisting of 1,4-bis[3-(3-perhydrodioxazepinyl-1,5,3)propyl]piperazine.
Claim 8
Dependent Claim 7 words
The composition of matter consisting of 1,4-bis[3-(3-perhydrodioxazepinyl-1,5,3)propyl]piperazine.

References Cited (Backward Citations)

US3786005A Cited
US3912689A Cited
US3925268A Cited
US4011223A Cited
US4012445A Cited
US3981829A Cited
US4251637A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-08-02 1986-02-01 1986-08-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-08-02 1990-02-01 1990-08-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-08-02 1994-02-01 1994-08-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag